These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1268854)
21. Effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and related compounds on nuclear RNA metabolism. Kann HE; Kohn KW; Widerlite L; Gullion D Cancer Res; 1974 Aug; 34(8):1982-8. PubMed ID: 4858341 [No Abstract] [Full Text] [Related]
22. Response of exponentially growing, stationary-phase, and synchronized cultured human colon carcinoma cells to treatment with nitrosourea derivatives. Drewinko B; Barlogie B; Freireich EJ Cancer Res; 1979 Jul; 39(7 Pt 1):2630-6. PubMed ID: 445465 [TBL] [Abstract][Full Text] [Related]
23. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard. Evans CG; Bodell WJ; Tokuda K; Doane-Setzer P; Smith MT Cancer Res; 1987 May; 47(10):2525-30. PubMed ID: 2882834 [TBL] [Abstract][Full Text] [Related]
24. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas. Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398 [TBL] [Abstract][Full Text] [Related]
25. Antitumor activity of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea (MeCCNU) on Yoshida sarcoma ascites cells implanted into the colon wall of rats. Bhide S; Habs M; Reinbold H; Schmähl D J Cancer Res Clin Oncol; 1979 May; 94(1):63-7. PubMed ID: 468900 [TBL] [Abstract][Full Text] [Related]
26. Growth response of B16 melanoma to in vivo treatment with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) at the initial stage after tumor transplantation. Li XH; Paulus G; Atassi G; Buyssens N Am J Pathol; 1984 Jun; 115(3):403-11. PubMed ID: 6731586 [TBL] [Abstract][Full Text] [Related]
27. Generation of phenotypic diversity in the B16 mouse melanoma relative to spontaneous metastasis. Stackpole CW Cancer Res; 1983 Jul; 43(7):3057-65. PubMed ID: 6850615 [TBL] [Abstract][Full Text] [Related]
28. A method to determine the carbamoylating potential of 1-(2-chloroethyl)-1-nitrosoureas. Stahl W; Krauth-Siegel RL; Schirmer RH; Eisenbrand G IARC Sci Publ; 1987; (84):191-3. PubMed ID: 2960614 [TBL] [Abstract][Full Text] [Related]
29. Review of mechanism of action studies of the nitrosoureas. Bono VH Cancer Treat Rep; 1976 Jun; 60(6):699-702. PubMed ID: 182364 [No Abstract] [Full Text] [Related]
30. Cytotoxicity and DNA damaging effects of a new nitrosourea, fotemustine, diethyl- 1-(3-(2-chloroethyl)-3-nitrosoureido) ethylphosphonate-S10036. Tapiero H; Yin MB; Catalin J; Paraire M; Deloffre P; Rustum Y; Bizzari JP; Tew KD Anticancer Res; 1989; 9(6):1617-22. PubMed ID: 2627116 [TBL] [Abstract][Full Text] [Related]
31. Effects of N,N'-bis(2-chloroethyl)-N-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-2-deoxy-D-glucopyranose upon the proliferation, DNA synthesis, and viability of cultured sensitive and resistant L1210 cells. Wheeler GP; Alexander JA; Adamson DJ Cancer Res; 1980 Oct; 40(10):3723-7. PubMed ID: 6449283 [TBL] [Abstract][Full Text] [Related]
32. Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas. Bodell WJ; Gerosa M; Aida T; Berger MS; Rosenblum ML Cancer Res; 1985 Aug; 45(8):3460-4. PubMed ID: 3860285 [TBL] [Abstract][Full Text] [Related]
33. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) inhibits prostate carcinoma cell growth via p53-dependent and p53-independent pathways. Huynh H; Nguyen TH; Panasci L; Do P Cancer; 2004 Dec; 101(12):2881-91. PubMed ID: 15529313 [TBL] [Abstract][Full Text] [Related]
34. In vivo clonogenic tumor cell kinetics following 1,3-bis(2-chloroethyl)-1-nitrosourea brain tumor therapy. Rosenblum ML; Knebel KD; Vasquez DA; Wilson CB Cancer Res; 1976 Oct; 36(10):3718-25. PubMed ID: 953998 [TBL] [Abstract][Full Text] [Related]
35. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity. Vassal G; Boland I; Terrier-Lacombe MJ; Watson AJ; Margison GP; Vénuat AM; Morizet J; Parker F; Lacroix C; Lellouch-Tubiana A; Pierre-Kahn A; Poullain MG; Gouyette A Clin Cancer Res; 1998 Feb; 4(2):463-8. PubMed ID: 9516937 [TBL] [Abstract][Full Text] [Related]
36. Cystemustine induces redifferentiation of primary tumors and confers protection against secondary tumor growth in a melanoma murine model. Demidem A; Morvan D; Papon J; De Latour M; Madelmont JC Cancer Res; 2001 Mar; 61(5):2294-300. PubMed ID: 11280801 [TBL] [Abstract][Full Text] [Related]
37. [Disruption of DNA synthesis and structure of mouse L1210 leukemia cells, sensitive and resistant to 1-methyl-1 nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in vivo]. Kukushkina GV; Peretolchina NM; Minenkova EA; Verovskiĭ VN; Sof'ina ZP Biokhimiia; 1984 Jul; 49(7):1189-98. PubMed ID: 6477985 [TBL] [Abstract][Full Text] [Related]
38. [Enhancement of the effects of anticancer agents on B16 melanoma cells by combination with cepharanthine--II. Antimetabolite, alkylating agent, nitrosourea]. Kubota R; Kubota K; Yamada S Gan To Kagaku Ryoho; 1992 Nov; 19(13):2169-74. PubMed ID: 1444482 [TBL] [Abstract][Full Text] [Related]
39. Effect of thymidine on uptake, DNA alkylation, and DNA repair in L1210 cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea or 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine. August EM; Prusoff WH Cancer Res; 1988 Aug; 48(15):4272-5. PubMed ID: 3390823 [TBL] [Abstract][Full Text] [Related]
40. [Cellular capacity in tissue culture and in tumors for recovery from the injuries induced by N-methyl-N-nitrosourea]. Chan Tik Canh ; Gotlib VIa; Afanas'ev GG; Pelevina II Tsitologiia; 1979 Oct; 21(10):1217-21. PubMed ID: 505572 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]